Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2015 · 10-Q
Revenue$5.44M$5.44M+10.1% vs Q3 2014 Net Income$7.83M$7.83M+3,209.6% vs Q3 2014 EPS Diluted$0.80$0.80+3,900.0% vs Q3 2014 Operating Income$1,264,316+194.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,018,070+9.5% Margins · derivedOperating margin23.3%+14.6 pt vs Q3 2014
Net margin144.0%+139.2 pt vs Q3 2014
ended Aug 31, 2015 · filed Oct 15, 2015 · 45 d after period end